Question

I am a breastfeeding mother and i want to know if it is safe to use 1,2-Dithia-5,8,11,14,17-penaazacycloeicosane, cyclic peptide deriv.? Is 1,2-Dithia-5,8,11,14,17-penaazacycloeicosane, cyclic peptide deriv. safe for nursing mother and child? Does 1,2-Dithia-5,8,11,14,17-penaazacycloeicosane, cyclic peptide deriv. extracts into breast milk? Does 1,2-Dithia-5,8,11,14,17-penaazacycloeicosane, cyclic peptide deriv. has any long term or short term side effects on infants? Can 1,2-Dithia-5,8,11,14,17-penaazacycloeicosane, cyclic peptide deriv. influence milk supply or can 1,2-Dithia-5,8,11,14,17-penaazacycloeicosane, cyclic peptide deriv. decrease milk supply in lactating mothers?

1,2-Dithia-5,8,11,14,17-penaazacycloeicosane, cyclic peptide deriv. lactation summary

1,2-Dithia-5,8,11,14,17-penaazacycloeicosane, cyclic peptide deriv. usage has low risk in breastfeeding
  • DrLact safety Score for 1,2-Dithia-5,8,11,14,17-penaazacycloeicosane, cyclic peptide deriv. is 3 out of 8 which is considered Low Risk as per our analyses.
  • A safety Score of 3 indicates that usage of 1,2-Dithia-5,8,11,14,17-penaazacycloeicosane, cyclic peptide deriv. may cause some minor side effects in breastfed baby.
  • Our study of different scientific research indicates that 1,2-Dithia-5,8,11,14,17-penaazacycloeicosane, cyclic peptide deriv. may cause moderate to no side effects in lactating mother.
  • Most of scientific studies and research papers declaring usage of 1,2-Dithia-5,8,11,14,17-penaazacycloeicosane, cyclic peptide deriv. low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
  • While using 1,2-Dithia-5,8,11,14,17-penaazacycloeicosane, cyclic peptide deriv. We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
  • Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About 1,2-Dithia-5,8,11,14,17-penaazacycloeicosane, cyclic peptide deriv. usage in lactation

Low risk. It is not secreted into breast milk because of a large molecular weight. It is readily destroyed by the child’s stomach acid milieu. It has an estrogenic effect. Theoretically, it may decrease breast milk production. Take into account the known anovulatory effect of breastfeeding. However, by taking this drug the opposite effect is desired.

Alternate Drugs for Gonadotropins & other Ovulation stimulants. ATC G03G

Clomiphene(Low Risk)
Clomifene Citrate(Low Risk)
Follitropin(Low Risk)
Chorionic Gonadotrophin Alpha(Low Risk)
Human Chorionic Gonadotrophin(Low Risk)
Human Menopausal Gonadotrophins(Low Risk)
Lutropin(Low Risk)
Menotropins(Low Risk)
Urofollitropin(Low Risk)
Lh(Low Risk)
Luteinising Hormone(Low Risk)
FSH(Low Risk)

Synonyms of 1,2-Dithia-5,8,11,14,17-penaazacycloeicosane, cyclic peptide deriv.

4-(L-Threonine)oxytocin
(4-Threonine)oxytocin
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.